Molecular docking has expanded from predicting interactions to repurposing drugs
In short: A review of molecular docking describes how this computer-based method, originally built to show how small molecules fit into larger ones, has taken on new roles in drug discovery. Beyond predicting such interactions, it is now being applied to flag possible side effects, explore how drugs act on multiple targets, and identify new uses for existing drugs.
Docking works by predicting how a candidate molecule interacts with a biological target without needing prior knowledge of other compounds that affect it, which lets researchers screen for promising compounds and map structure-activity relationships.
This is a review summarizing existing applications and future directions, including combining docking with artificial intelligence, rather than a report of new experimental results, so it doesn't provide fresh data testing these newer uses.
Why it matters: Molecular docking has grown from a tool for understanding molecular recognition into a broader platform for predicting drug safety and repurposing.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Source: Research: Pinzi and Rastelli (2019). Molecular Docking: Shifting Paradigms in Drug Discovery. International Journal of Molecular Sciences. · cc-by
To cite this card, link to https://intellectplus.co.uk/app/technology-research-molecular-docking-has-evolved-from-simple-structure-analysis.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Medicines · More in Health · Latest · A–Z · All topics